THE ROLE OF DIOLEOYL PHOSPHATIDYLETHANOLAMINE IN CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER

被引:680
|
作者
FARHOOD, H [1 ]
SERBINA, N [1 ]
HUANG, L [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,PITTSBURGH,PA 15261
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 1995年 / 1235卷 / 02期
关键词
TRANSFECTION; CATIONIC LIPOSOME; LIPOSOME; GENE THERAPY; ENDOCYTOSIS;
D O I
10.1016/0005-2736(95)80016-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a reporter gene assay, cationic liposomes containing the cationic lipid 3 beta-(N-(N',N'-dimethylaminoethane)carbamoyl)cholesterol (DC-Chol) and a neutral phospholipid dioleoylphosphatidylethanolamine (DOPE) showed high transfection activity. DNA/liposome complex which contained low amount of liposomes could bind to the cell surface but failed to transfect the cells. We have designed a two-step protocol to examine this phenomenon in more detail. A431 human cells were incubated on ice (pulse) with DNA complexed to a low level of cationic liposomes. The cells were washed and incubated at 37 degrees C (chase) with or without free cationic liposomes of various composition (helper liposomes). Only liposomes enriched with DOPE showed helper activity; liposomes containing dioleoylphosphatidylcholine (DOPC), a structural analog of DOPE, had no helper activity. The delivery was inhibited by the lysosomotropic agent chloroquine and was optimal if the helper liposome chase was initiated immediately after the pulse. An endocytosis model of DNA delivery by cationic liposomes is proposed in which the principal function of the chase liposomes is to destabilize the endosome membrane and allow the release of DNA into the cytosol. This model is consistent with the known activity of DOPE to assume non-bilayer structures, hence destabilizing the endosome membrane.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 50 条
  • [41] LIPOSOME-MEDIATED IN-VIVO GENE-TRANSFER TO RAT-KIDNEY TUBULAR CELLS
    MADRY, H
    BOHLENDER, J
    RESZKA, R
    GANTEN, D
    WAGNER, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 630 - 630
  • [42] LIPOSOME-MEDIATED IN-VIVO GENE-TRANSFER INTO DIFFERENT TISSUES OF THE GASTROINTESTINAL-TRACT
    SCHMID, RM
    WEIDENBACH, H
    DRAENERT, GF
    LERCH, MM
    LIPTAY, S
    SCHORR, J
    BECKH, KH
    ADLER, G
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1994, 32 (12): : 665 - 670
  • [43] The role of the blood proteins in gene transfection of cationic liposome-mediated gene delivery system
    Zhang, JS
    Huang, L
    MOLECULAR THERAPY, 2003, 7 (05) : S216 - S216
  • [44] LIPOSOME-MEDIATED IN-VIVO GENE-TRANSFER INTO THE ESOPHAGUS WALL IN AN ANIMAL-MODEL
    SCHMID, RM
    WEIDENBACH, H
    DRAENERT, GF
    LIPTAY, S
    BECKH, K
    ADLER, G
    GASTROENTEROLOGY, 1995, 108 (04) : A535 - A535
  • [45] CATIONIC LIPOSOME-MEDIATED TRANSFECTION
    FELGNER, PL
    RINGOLD, GM
    NATURE, 1989, 337 (6205) : 387 - 388
  • [46] Potentiation of cationic liposome-mediated gene delivery by polycations
    Gao, X
    Huang, L
    BIOCHEMISTRY, 1996, 35 (03) : 1027 - 1036
  • [47] Polycation liposome-mediated gene transfer in vivo
    Matsuura, M
    Yamazaki, Y
    Sugiyama, M
    Kondo, M
    Ori, H
    Nango, M
    Oku, N
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1612 (02): : 136 - 143
  • [48] Liposome-mediated gene transfer to lung isografts
    Boasquevisque, CHR
    Lee, TC
    Mora, BN
    Peterson, D
    Osburn, WO
    Bernstein, M
    Zhang, W
    Nietupski, JB
    Scheule, RK
    Cooper, JD
    Botney, MD
    Patterson, GA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (05): : 783 - 791
  • [49] Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo
    Baccaglini, L
    Hoque, ATMS
    Wellner, RB
    Goldsmith, CM
    Redman, RS
    Sankar, V
    Kingman, A
    Barnhart, KM
    Wheeler, CJ
    Baum, BJ
    JOURNAL OF GENE MEDICINE, 2001, 3 (01): : 82 - 90
  • [50] Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
    J A Reddy
    C Abburi
    H Hofland
    S J Howard
    I Vlahov
    P Wils
    C P Leamon
    Gene Therapy, 2002, 9 : 1542 - 1550